Patients with type 1 diabetes need to use insulin throughout their life to maintain life, and even regular use of insulin cannot simulate the physiological endogenous insulin secretion pattern (15), resulting in large fluctuations in blood sugar, enhanced health care costs (16), and reduced quality of life (17). The gene discussed is INS; the disease is type 1 diabetes mellitus.